SPEAKER FACULTY

Adam Freund

CEO

Arda Therapeutics

Alex Barron

Principal Scientist II

Novartis

ANDREW JOHN Whittle

Director, BD&L

Boehringer Ingelheim

Anil Karihaloo

Sr Principal Res Scientist

Novo Nordisk

Chan whiting

cso

Deciduous Therapeutics

David Lagares

CEO

Zenon Biotech

Eric Campeau

Vice President Translational Research

Thryv Therapeutics

Francesco Del Galdo

Professor of Experimental Medicine

Leeds Institute of Rheumatic and Musculoskeletal Medicine

Geoffrey Teixeira

Senior Vice President & Head of Fibrosis

Alentis Therapeutics

Jack Castle

Director - Corporate Strategy & Business Development

Ochre Bio

Jen-Chieh(Jay) Chuang

Director - Liver diseases & Translational Biomarker Lead

Takeda

Jijun Dong

Chief Scientific Officer

Salubris

Johan Raud

Chief Scientific Officer

Vicore Pharma

Joseph Wu

Professor

Stanford University

Katie McCauley

Head of Fibrosis Research

Novartis

Kevin Hart

Director - Scientific & Associate Research Fellow

Pfizer

Lee Borthwick, COO, Fibrofind, 8th Antifibrotic Drug Development Summit 2024

Lee Borthwick

Chief Operating Officer & Director

FibroFind

Marc Hertz

President & CEO

GRI Bio

Ole J. Kaasboell

Chief Scientific Officer

Tribune Therapeutics

Scott Turner

CSO

Arda Therapeutics

Seulki Lee

Founder and CEO

D&D Pharmatech

Timothy McKinsey

Professor

University of Colorado Denver

Ulrika WARPMAN BERGLUND

Chief Executive Officer

Oxcia

FULL EVENT GUIDE
REGISTER
PARTNER